Nucleostemin expression in breast cancer is a marker of more aggressive phenotype and unfavorable patients’ outcome: A STROBE-compliant article

Cancer stem cells (CSCs) are postulated to play significant role in the pathogenesis, progression as well as drug resistance of breast cancer. Nucleostemin (NS) is thought to be a key molecule for stemness, and the clinical impact of NS immunoreactivity in breast cancer can indicate its actual role...

Descripción completa

Detalles Bibliográficos
Autores principales: Sami, Manal M., Hachim, Mahmood Y., Hachim, Ibrahim Y., Elbarkouky, Ahmed H., López-Ozuna, Vanessa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5750
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831441/
https://www.ncbi.nlm.nih.gov/pubmed/30817632
http://dx.doi.org/10.1097/MD.0000000000014744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831441/
https://www.ncbi.nlm.nih.gov/pubmed/30817632
http://dx.doi.org/10.1097/MD.0000000000014744

Ejemplares similares